News & Updates
Filter by Specialty:
Fewer hospitalizations with omicron vs delta suggest reduced severity of omicron variant
Infection with the omicron variant of SARS-CoV-2 was less likely to result in hospitalization than infection with the delta variant, according to an observational study from Denmark presented at ECCMID 2022 and published in The Lancet.
Fewer hospitalizations with omicron vs delta suggest reduced severity of omicron variant
23 May 2022
Different booster shot strengthens immune response against Omicron
Getting a different type of mRNA vaccine for the booster shot leads to a stronger neutralizing immune response against the COVID-19 Omicron variant, according to a recent Singapore study.
Different booster shot strengthens immune response against Omicron
23 May 2022
Male sex, obesity among risk factors for severe COVID-19 in children
A large study by the US National COVID Cohort Collaborative (N3C) has identified factors associated with the risk of severe disease among children with SARS-CoV-2 infection as well as factors tied to an increased risk of multisystem inflammatory syndrome in children (MIS-C) as compared to acute COVID-19.
Male sex, obesity among risk factors for severe COVID-19 in children
20 May 2022
Investigational drug gains upper hand over placebo in reducing CDI recurrence rates
SER-109, an investigational oral microbiome therapeutic, achieves superiority over placebo in reducing recurrent Clostridioides difficile infection (CDI) rates, according to updated findings from the phase III ECOSPOR-III trial.
